Earningsreport

Q1/2025 3/31/2025 EPS -0.350 ZacksConsensus -0.250 ActVsEst (0.100) - Miss

AN2 Therapeutics, Inc.  (ANTX) 
US:NYSE Investor Relations: ir.antheminc.com